The dual-adjuvant logic of mRNA vaccines
Trends in Immunology · 2026-04 · 47 (4) · 243-245
DOI: 10.1016/j.it.2026.01.012 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Immunology, 2026-04. Verfasst von R Dilshan Malewana und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Adjuvants, Vaccine, mRNA Vaccines, Immunity, Humoral, Nanovaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
- Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address: kizzmekia_corbett@hsph…
Zitieren
APA
Malewana, R. D., & Corbett-Helaire, K. S. (2026). The dual-adjuvant logic of mRNA vaccines. Trends in Immunology, 47(4), 243-245. https://doi.org/10.1016/j.it.2026.01.012
Vancouver
Malewana RD, Corbett-Helaire KS. The dual-adjuvant logic of mRNA vaccines. Trends in Immunology. 2026;47(4):243-245. doi:10.1016/j.it.2026.01.012
BibTeX
@article{Malewana2026,
author = {Malewana, R Dilshan and Corbett-Helaire, Kizzmekia S},
title = {The dual-adjuvant logic of mRNA vaccines},
journal = {Trends in Immunology},
year = {2026},
volume = {47},
number = {4},
pages = {243--245},
doi = {10.1016/j.it.2026.01.012}
}
EUVIMED